Emergent BioSolutions (EBS) Share-based Compensation (2010 - 2026)

Emergent BioSolutions' Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 26.67% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $16.6 million (up 22.06% YoY), while the FY2025 annual figure was $16.2 million, down 10.0% from the prior year.
• Share-based Compensation was $1.9 million for Q1 2026 at Emergent BioSolutions, down from $5.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $12.3 million in Q2 2022 to a low of $1.5 million in Q1 2025.
• Historically, Share-based Compensation has averaged $6.1 million across 5 years, with a median of $5.3 million in 2025.
• Biggest YoY gain for Share-based Compensation was 108.7% in 2025; the steepest drop was 74.58% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $11.7 million in 2022, then sank by 65.81% to $4.0 million in 2023, then increased by 7.5% to $4.3 million in 2024, then grew by 23.26% to $5.3 million in 2025, then sank by 64.15% to $1.9 million in 2026.
• The last three Share-based Compensation figures came in at $1.9 million (Q1 2026), $5.3 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.